Latest Forum Topics /
UGHealthcare
Last:0.084
-0.002
|
 Post Reply
|
|
UGHealthcare share worth keeping?
|
|||||
|
Longtermer
Elite |
20-Sep-2022 16:25
Yells: "A disciplined investor is a wealthy investor" |
||||
|
x 0
x 0 Alert Admin |
Thanks for posting contacts. UG did a lot to expand up and down stream. Balance sheet and ratios cannot be better with its net cash and growing rev and profits over last 2 to 3 years. But they are not doing much to reward shareholders via shares buyback to support stock price trading nearly half of their NAV of 37c. The buyback benefits shareholders by increasing the percentage of ownership held by each investor by reducing the total number of outstanding shares. In the case of a buyback the company is concentrating its shareholder value rather than diluting it which is good when the price is almost 50% discount. The company can also save the dividend of 0.64c per share. All of us can write in to bod to ask them why.. AGM is coming soon and is a good time to check them out. UG trading 19.9 c with 0.64c otw.. Dyodd.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
19-Sep-2022 17:31
|
||||
|
x 0
x 0 Alert Admin |
The share was quite badly smashed but noticed some support in the afternoon. Price is quite on par with Top Glove . | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Edward555
Member |
19-Sep-2022 09:58
|
||||
|
x 0
x 0 Alert Admin |
If need more info or engaghe them, san call or email below contacts taken from their website: UG Healthcare Office 38 Beach Road #29-11 South Beach Tower Singapore 189767 Tel: (60) 6677 2751/2 Rosalina Soh Mobile 9677 6683 Email: [email protected] Mr. Yip Wah Pung, Chairman of AC: Tel: +6012-201-6881 Email: [email protected] / [email protected]
|
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
19-Sep-2022 09:57
|
||||
|
x 0
x 0 Alert Admin |
I think its also sentiment driven with a rather negative view on glove stocks. It seems the company is doing all it can but since the other glove stocks have been dropping there could be some switching to those glove stocks that have dropped much more recently. Larger ivestors are aware of what is going on in the market so it is up to them to call the shots. | ||||
| Useful To Me Not Useful To Me | |||||
|
Edward555
Member |
19-Sep-2022 08:33
|
||||
|
x 0
x 0 Alert Admin |
They need better investor relations to engage the market.
Price now close to cash they have in bank. Nav 37c and trading 20c and still no shares buy back? Yes, should ask them during agm.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Longtermer
Elite |
17-Sep-2022 09:47
Yells: "A disciplined investor is a wealthy investor" |
||||
|
x 0
x 0 Alert Admin |
Unigloves announcement on linkedin.. Unigloves is expanding across Europe! We are entering an exciting time for Unigloves and have recently identified that our customers and Distribution partners will benefit from a local Sales Office. Therefore, we are happy to announce the opening of Unigloves offices in Bulgaria with plans for new offices in Poland, Romania and other European markets over the coming months. From this base, we plan to grow our European Sales Team to ensure that our international customers will receive the same excellent customer service that you' re used to receiving from Unigloves - in their local language. These new developments are in support of our new Unigloves vision, to be the leading and most responsible hand protection manufacturer in the world. We are currently recruiting for a Regional Sales Manager and Country Manager in Poland. If you are interested in joining the Unigloves team, please get in touch: https://bit.ly/3DhzEUt |
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
13-Sep-2022 10:43
|
||||
|
x 0
x 0 Alert Admin |
I see some sellers at 0.215, could be the same guys who bougt them earlier testing the market ? or trying to collect cheaper ? not sure I threw out some as well but intend to buy it back when the share comes back to life. Share remains undervalued but market ignoring it. |
||||
| Useful To Me Not Useful To Me | |||||
|
ETHunter
Master |
06-Sep-2022 20:28
|
||||
|
x 0
x 0 Alert Admin |
Agm coming soon. Can ask boss to share on their distribution and diversification plans, share buy backs and dividend policy etc. UG grew substantially over last 2 years due to Covid. Good luck. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Richardlai
Master |
06-Sep-2022 17:03
|
||||
|
x 0
x 0 Alert Admin |
General stock market looks quite dead and flat. Seems nothing much may happen to this share as well ... | ||||
| Useful To Me Not Useful To Me | |||||
|
ETHunter
Master |
31-Aug-2022 20:30
|
||||
|
x 0
x 0 Alert Admin |
Lot of accumulation at 21.5c recently. Dividend 0.64c otw. Cash on hand 100m or 16c per share.
Someone said could be a buyout counter by SSH who own more than 70%.
My guess is UG most likely to move up soon, chasing RS.
Goodluck. |
||||
| Useful To Me Not Useful To Me | |||||
|
eric998
Supreme |
31-Aug-2022 18:53
|
||||
|
x 0
x 0 Alert Admin |
High chance go below 20c, trade with care.. | ||||
| Useful To Me Not Useful To Me | |||||
|
ETHunter
Master |
31-Aug-2022 16:50
|
||||
|
x 0
x 0 Alert Admin |
UG bosses so far did not do share buy back for the company even though they have the shareholders mandate at every AGM. Need to query them why they did not support share prices which is trading at 21c vs NAV 37c. Really undervalued. Its time supporters write to them to do something. Goodluck to all. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Longtermer
Elite |
31-Aug-2022 11:01
Yells: "A disciplined investor is a wealthy investor" |
||||
|
x 0
x 0 Alert Admin |
UG and RS have unique gloves products and marketing strategies that can differentiate them from peers. Both cash rich and profitable companies. UG to catch up with RS soon imo. Dyodd and huat.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
30-Aug-2022 10:13
|
||||
|
x 0
x 0 Alert Admin |
Yes it has done exceptionally well due to the pandemic. Glove prices have been trending down so it could cause some concern, but with a share that is far below its net assets and having a lot of cash, it should be quite safe.
|
||||
| Useful To Me Not Useful To Me | |||||
|
ETHunter
Master |
30-Aug-2022 10:00
|
||||
|
x 0
x 0 Alert Admin |
UG has been pressed down for a long time. Company is building its growth path from below. Hope it will move to right valuation at 7 to 8 times PE soon. | ||||
| Useful To Me Not Useful To Me | |||||
|
Longtermer
Elite |
27-Aug-2022 19:59
Yells: "A disciplined investor is a wealthy investor" |
||||
|
x 0
x 0 Alert Admin |
UNIGLOVESA safe pair of hands In business for more than three decades, Unigloves is cementing its place as a leader in the manufacture of hand protection products, and is pushing boundaries with a new sustainable range: BioTouch. Since 1989, protective products manufacturer Unigloves has been saving lives across the world by protecting hands and preventing the spread of disease. Beginning with two friends: Mr Lee, an engineer, and Mr. Ang, a teacher, who started manufacturing rubber gloves in Malaysia to support the increased demand following the Aids pandemic, the company first launched operations in Germany and the US, before expanding into five continents, supplying hand protection advice and products to over 50 countries. Today, Unigloves produces the majority of the gloves that it sells within its group-owned factories. It&rsquo s a characteristic that&rsquo s unique among branded glove manufacturers, and that allows the company to achieve product consistency, exert greater control over its inventory and supply chain, and invest in research and development. Our product range is 100-percent focused on hand protection,&rdquo confirms Chris Wahlers, Managing Director, UK at Unigloves. &ldquo The majority of our competitors have diversified into other forms of PPE and industrial workwear, or have branched out into a broader range of disposable products. However, we feel there is still value in our specialist expertise, and plenty of room for innovation in the hand protection sector. One such innovation is BioTouch, a new glove containing biodegradable technology, designed to speed up the organic breakdown process. &ldquo With BioTouch, we&rsquo re able to achieve biodegradation of 90 percent in 490 days, as opposed to traditional nitrile gloves that can take up to 100 years,&rdquo Chris explains. &ldquo This new biodegrading technology is achieved thanks to an organic additive, which attracts microbes found in landfills, but does not impair the gloves&rsquo performance or real-time shelf life. The development of the BioTouch gloves sits within Unigloves broader sustainability strategy &ndash developed in partnership with the LifeWork Group &ndash which sets out to establish the company as the best-in-class sustainability leader in the UK hand protection market. Its indicative of the company&rsquo s collaborative mindset, one that it brings in equal measure to its product development. Most often, new ideas are customer-driven, but they can also originate from the team, suppliers, or new partners,&rdquo Chris tells us. &ldquo Although most of our manufacturing is done in-house, the market for hand protection is large, and we believe collaboration can be more efficient than competition, so we also include third-party producers in our NPD process. In addition to natural product evolution, and some new sustainable products, we are also working on two key concept projects relating to fast-growing sectors, which we hope to bring to fruition over the next 12 months, Chris adds. &ldquo One is a technology developed with Cambridge University, to be incorporated into our medical products range. The other is a brand-new product to help capitalise on a fast-growing vertical. A constant throughout more than three decades of success, Malaysia continues to provide the core of the company&rsquo s operations, playing host to a total of four Unigloves factories. Nevertheless, as it looks to capitalise on a successful few years, the company is investing heavily in its footprint, as it works to expand its upstream and downstream ERP systems. Glove production lines are complex beasts, requiring input during design from architects, engineers, and technologists, Chris comments. &ldquo Our newest lines are already very efficient, but still require significant human input, so we are continuing to invest to reduce our reliance on manual labour and automate our production with robotics. Given the global nature of our business, its also important for us to focus on synergies in our downstream distribution offices, where improving our operational efficiency is one of the six pillars of our strategy,&rdquo he goes on. &ldquo In the short term, this means consolidating back-office functions, warehousing, and logistics at a regional level, but in the medium-term it means global systems, AI-led innovation, and an international business strategy. Among its planned investments, the company is introducing a new PIM system. Intended to centralise Unigloves complete range of product data, its expected to provide distributors with real-time information, pushing product data across the companys website, catalogues, and associated materials. &ldquo It&rsquo s about improving consistency, and supporting our diversification of products, services, and regions,&rdquo Chris notes. &ldquo With our supply chain partners, our goal is always to make ourselves an integral part of their team. Some days we&rsquo re their category manager, some days their marketing team, and other days part of their sales team. We&rsquo re bringing leads, investing in co-marketing, and driving new products into the market. At the same time, we also work with our customers to truly understand their business and their problems, he develops. Through that, we can identify new and better ways to support them. This means a team of boots on the ground, getting into the detail with the users of the product. For Chris, its those boots on the ground who, ultimately, serve as Unigloves driving force. A business is nothing without the people it&rsquo s made up of, he insists. Fortunately, that starts with the owners of the group, and Kevin Onah, who started our UK operations in 2002. They&rsquo ve been endlessly encouraging, and we try to encourage the same ethos in our team. &ldquo We&rsquo re working with Diversio, the world&rsquo s first AI-based DEI platform, to ensure that Diversity, Equity and Inclusion are at the forefront of our people plan,&rdquo he continues. Although we&rsquo re a team of almost 1000 globally, we&rsquo re still a family business, and we want people to be emotionally involved, even as our operations become more complex and process driven. As we&rsquo ve worked on developing our strategy, we&rsquo ve tried to encourage everyone to engage in that process, and feel that they are part of something larger than themselves. Looking ahead to the next five years, Chris is clear that Unigloves goal is to have its brand, people, products, and operations admired and regarded as influential, and to be a force for good in the hand protection market. We&rsquo d like to expand our market presence in front of end-users, celebrate the work they do, and really impress upon them our expertise and desire to help protect their workforce,&rdquo he concludes. &ldquo We&rsquo re hopeful that we&rsquo ll be able to achieve greater presence amongst our customers and our distributor partners, broaden our geographic reach, drive further operational efficiency, and establish additional income streams... https://scw-mag.com/profiles/unigloves/ |
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
26-Aug-2022 11:44
|
||||
|
x 0
x 0 Alert Admin |
Logically it is a buy, but the share seems to have a problem moving up. Some analysts did recommend it as a buy earlier, so we need to see their latest recommendations. Value wise it is cheap but share price movement is not easy to predict, wonder if the Funds find it too small to bother.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
26-Aug-2022 10:27
|
||||
|
x 2
x 0 Alert Admin |
UG Healthcare' s 2HFY2022 earnings down by 75.6% to $15.5 mil, proposes special dividend
UG Healthcare Corp has reported earnings of $15.5 million for the 2HFY2022 ended June, 75.6% lower than the net profit of $63.8 million in the same period the year before.
FY2022 earnings stood at $36.8 million, down 69% y-o-y from FY2021' s $118.7 million.
Earnings per share (EPS) for 2HFY2022 stood at 2.48 cents, compared to 10.37 cents for 2HFY2021.
EPS for FY2022 stood at 5.93 cents, compared to 19.42 cents for FY2021.
Revenue fell 35.6% y-o-y to $115.3 million from $179 million for 2HFY2021, while FY2022 revenue fell 31.3% y-o-y to $232.5 million.
Although demand remains strong for hand protection for safety and hygiene purposes, the company says the rapid downward adjustments in average selling price (ASP) of disposable examination gloves to pre-Covid levels from the increase in global supply resulted in its customers&rsquo preference to hold lower inventory.
This underscored UG Healthcare&rsquo s weaker financial performance for FY2022 as more countries progress from the pandemic to endemic phase.
The company reported gross profit of $39.8 million for 2HFY2022, 58.9% down y-o-y from $97 million for 2HFY2021.
FY2022 gross profit decreased by 57% y-o-y from $196.2 million to $84.4 million. This was in tandem with the lower revenue from lower ASP across all product segments, partially offset by lower raw material prices despite an increase in production volume.
Correspondingly, gross profit margin declined from 58% in FY2021 to 36.3% in FY2022.
UG Healthcare&rsquo s net asset value increased from $190.6 million as at June 30, 2021 to $228.9 million as at June 30 this year. Similarly, net asset value increased from 30.93 cents as at June 30, 2021 to 36.69 cents as at June 30 this year.
The group&rsquo s net cash position stood at approximately $83.8 million as at June 30.
As a token of appreciation to shareholders, UG Healthcare has proposed a special dividend of 0.32 cents per share and a final dividend of 0.32 cents per share. The total dividend of 0.64 cents for FY2022 is a slight increase from FY2021&rsquo s 0.611 cents.
UG Healthcare executive director and finance director Lee Jun Yih says the company will build its downstream distribution capabilities in its pursuit to expand its product portfolio and correspondingly broaden its earnings base which it believes will give an edge to achieving sustainable growth in the long term.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Edward555
Member |
26-Aug-2022 10:09
|
||||
|
x 0
x 0 Alert Admin |
Profit 37m and dividend 0.64c. Cash on hand 100m and Nav 37c Can buy?
|
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
26-Aug-2022 09:16
|
||||
|
x 0
x 0 Alert Admin |
The result is as per expectation. Quite surprised there was a lack of workers for their extended factory, if not, we could expect a higher sales figure. Good of them to try and reward with bonus dividend. |
||||
| Useful To Me Not Useful To Me | |||||